Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Efficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain Sweden
  • Study on Heart Amyloidosis Using Sodium Fluoride (18F) and Iodine (123I) Iobenguane for Patients with Transthyretin Amyloid Cardiomyopathy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Long-term safety study of NNC6019-0001 for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Czechia France Germany Italy The Netherlands Portugal +1
  • Study on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)

    Not recruiting

    2 1
    Investigated Diseases:
    Czechia France Germany Italy The Netherlands Portugal +1
  • Study on the Effects and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy

    Not recruiting

    2 1 1
    Investigated Drugs:
    France Germany The Netherlands Spain
  • Study on How Tafamidis is Absorbed in the Blood of Healthy Adults with Transthyretin Amyloid Cardiomyopathy

    Not recruiting

    1 1 1
    Investigated Drugs:
    Belgium
  • Study to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark France Italy +5
  • Study on the Use of Flutemetamol (18F) for Diagnosing Cardiac Amyloidosis in Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France Italy The Netherlands +2
  • Study on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark Greece Ireland Italy +3